A new report demonstrates for the first time the ability of COVID-19 vaccines to penetrate the fetal-placental barrier and reach the intrauterine environment.
People who have moderate to severe COVID-19 prior to vaccination may have increased reactogenicity to COVID-19 vaccines, according to a Canadian study.